exisulind
Sponsors
University of Utah, M.D. Anderson Cancer Center, Alliance for Clinical Trials in Oncology, Eastern Cooperative Oncology Group, Astellas Pharma Inc
Conditions
Breast NeoplasmsColorectal CancerLung CancerMetastases, NeoplasmNSCLCNon-Small Cell Lung CancerProstate CancerProstatic Neoplasms
Phase 1
Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer Patients
CompletedNCT00037609
Start: 2001-01-31End: 2003-02-28Updated: 2012-10-24
Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients
CompletedNCT00072618
Start: 2001-10-31End: 2003-08-31Target: 52Updated: 2011-10-20
Phase 2
Docetaxel, Estramustine, and Exisulind in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
CompletedNCT00052845
Start: 2002-11-30End: 2009-04-30Updated: 2016-07-01
Combination Chemotherapy and Exisulind in Treating Patients With Extensive-Stage Small Cell Lung Cancer
CompletedNCT00041054
Start: 2002-06-30End: 2008-02-29Updated: 2016-12-07
Combination Chemotherapy in Treating Patients With Advanced Non-Small Cell Lung Cancer
CompletedNCT00041314
Start: 2002-10-04End: 2007-06-15Updated: 2023-06-15
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
WithdrawnNCT00026468
Start: 1999-07-31End: 1999-07-31Updated: 2013-07-24
Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer
CompletedNCT00078910
Start: 2003-08-31End: 2006-09-30Target: 130Updated: 2013-06-24
Exisulind Versus Placebo After Surgical Removal of the Prostate
CompletedNCT00166426
Start: 2003-02-28End: 2008-05-31Target: 240Updated: 2009-11-16
Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer
CompletedNCT00283803
Start: 2002-03-12End: 2011-10-31Updated: 2018-08-07